glp-1 needles New Guidelines on Drugs for Obesity Released No needles? Yep. The first

Liraglutide is a medication that is classified as a glucagon-like peptide-1 (GLP-1) receptor agonist

Insulin resistance can be defined as a reduced sensitivity to the action of insulin within target tissue [135]

This may strengthen the case for studying GLP-1 medications as potentially helpful tools for both prevention and reducing the consequences of substance use in addiction care, especially for people who already have a clear medical reason to receive them

However, while data in mouse models are promising, there are currently no therapies currently in clinical trials focused on GPCR signaling to increase plasma GLP-1